The silencing of endoglin in B16F1 and B16F10 melanoma variants resulted in a statistically significant decrease in spheroid growth by approximately 45% and 40%, respectively, at day 2 compared to the growth of spheroids that were formed from untreated cells, and 35% and 25% compared to GET of pControl (Figure 3B). The gene discussed is ENG; the disease is melanoma.